HLA-A and glioblastoma: Regarding glioblastoma, the first HLA peptidome publications described the HLA-ligandome of HLA-A*02 (the most frequent HLA class I allotype in Caucasians) including immunogenicity testing of the most promising candidates and the ligandome of non-HLA-A*02 allotypes (106, 107).